Nanosonics Limited (NNCSF – Research Report) received a Hold rating and a A$5.00 price target from Wilsons analyst Shane Storey yesterday. The company’s shares closed last Friday at $3.00.
Storey covers the Healthcare sector, focusing on stocks such as CSL, Fisher & Paykel Healthcare Corporation Limited, and Nanosonics Limited. According to TipRanks, Storey has an average return of 4.1% and a 57.78% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Nanosonics Limited with a $3.17 average price target, which is a 5.67% upside from current levels. In a report released on January 20, Canaccord Genuity also maintained a Hold rating on the stock with a A$5.00 price target.
See the top stocks recommended by analysts >>
Based on Nanosonics Limited’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $0. In comparison, last year the company had a net profit of $0
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Nanosonics Ltd is an Australia based healthcare equipment manufacturing company. It manufactures and distributes the trophon EPR ultrasound probe disinfector, which reduces the risk of ultrasound-related cross-infection. It also manufactures the associated consumables and accessories such as the trophon wall mount, trophon printer, trophon cart, trophon curved probe positioner and others. In addition, the company manufactures and commercializes infection control and decontamination products and services and related technologies. The entity operates in Australia and other countries, of which key revenue is derived from North America.
